-DOCSTART- -X- O
Noroviruses -X- _ O
( -X- _ O
NoVs -X- _ O
) -X- _ O
are -X- _ O
one -X- _ O
of -X- _ O
the -X- _ O
leading -X- _ O
causes -X- _ O
of -X- _ O
acute -X- _ O
gastroenteritis -X- _ O
worldwide. -X- _ O
NoV -X- _ O
GII-4 -X- _ O
VP1 -X- _ O
protein -X- _ O
was -X- _ O
expressed -X- _ O
in -X- _ O
a -X- _ O
recombinant -X- _ O
baculovirus -X- _ O
system -X- _ O
using -X- _ O
Sf9 -X- _ O
insect -X- _ O
cells. -X- _ O
Several -X- _ O
methods -X- _ B-Intervention
for -X- _ I-Intervention
purification -X- _ I-Intervention
and -X- _ I-Intervention
concentration -X- _ I-Intervention
of -X- _ O
virus-like -X- _ B-Patient
particles -X- _ I-Patient
( -X- _ I-Patient
VLPs -X- _ I-Patient
) -X- _ I-Patient
were -X- _ O
evaluated. -X- _ O
Electron -X- _ B-Outcome
microscopy -X- _ I-Outcome
( -X- _ I-Outcome
EM -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
histo-blood -X- _ I-Outcome
group -X- _ I-Outcome
antigen -X- _ I-Outcome
( -X- _ I-Outcome
HBGA -X- _ I-Outcome
) -X- _ I-Outcome
binding -X- _ I-Outcome
assays -X- _ I-Outcome
showed -X- _ I-Outcome
that -X- _ I-Outcome
repeated -X- _ I-Outcome
sucrose -X- _ I-Outcome
gradient -X- _ I-Outcome
purification -X- _ I-Outcome
followed -X- _ I-Outcome
by -X- _ I-Outcome
ultrafiltration -X- _ I-Outcome
resulted -X- _ I-Outcome
in -X- _ I-Outcome
intact -X- _ I-Outcome
VLPs -X- _ I-Outcome
with -X- _ I-Outcome
excellent -X- _ I-Outcome
binding -X- _ I-Outcome
to -X- _ I-Outcome
H -X- _ I-Outcome
type -X- _ I-Outcome
3 -X- _ I-Outcome
antigens. -X- _ I-Outcome
VLPs -X- _ I-Outcome
were -X- _ I-Outcome
stable -X- _ I-Outcome
for -X- _ I-Outcome
at -X- _ I-Outcome
least -X- _ I-Outcome
12 -X- _ I-Outcome
months -X- _ I-Outcome
at -X- _ I-Outcome
4Â°C -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
up -X- _ I-Outcome
to -X- _ I-Outcome
7 -X- _ I-Outcome
days -X- _ I-Outcome
at -X- _ I-Outcome
ambient -X- _ I-Outcome
temperature. -X- _ I-Outcome
These -X- _ I-Outcome
findings -X- _ I-Outcome
indicate -X- _ I-Outcome
that -X- _ I-Outcome
this -X- _ I-Outcome
method -X- _ I-Outcome
yielded -X- _ I-Outcome
stable -X- _ I-Outcome
and -X- _ I-Outcome
high-quality -X- _ I-Outcome
VLPs -X- _ I-Outcome
. -X- _ O

